Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dryello (Tolnaftate 1%) Stick for Tinea Pedis
NCT07245667Phase 2Recruiting
- Sponsor
- ProPedix
- Start
- Dec 2024
- Primary completion
- Feb 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of tolnaftate in tinea pedis, sponsored by ProPedix. Started Dec 2024; status: recruiting.
02
Drugs
tolnaftate
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT07245667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245667.